The UIVentures program assists university inventors in creating new ventures based on their research.
We provide education and mentoring to advance entrepreneurs and emerging growth companies by linking them with the capital, talent and other critical resources they need for success.
The University of Iowa is a NSF I-Corps site managed by UIVentures and JPEC. Our program offers workshops to introduce faculty, staff, (and now) graduate students and postdocs to research commercialization. Their product or service, is called their intellectual property or IP, and is typically based on research discoveries or inventions achieved in a UI lab.
Voxello, the producer of the noddle, a medical device that helps impaired patients communicate with nurses and caregivers, has received FDA clearance for the trademarked device, and recently closed a Series A funding round of more than $800,000.
Immortagen Inc., based in Iowa City, a cancer diagnostics company that develops cloud-based precision medicine using a proprietary software platform, received a $100,000 loan from the Demonstration Fund for proof of concept work and key personnel.
Market: Cancer Genome Sequencing
Immortagen seeks to personalize cancer treatment through private tumor banking, full spectrum genetic profiling, revolutionary Clinical Decision Support algorithms, and advanced mouse models for drug research and development.
